Department of General Surgery and Organ Transplantation, University of Bologna, Italy.
Ann Surg. 2012 Nov;256(5):706-12; discussion 712-3. doi: 10.1097/SLA.0b013e3182724ce8.
: To evaluate the efficacy of preoperative liver stiffness (LS) measurement in predicting postoperative liver failure (PLF) after hepatectomy for hepatocellular carcinoma (HCC).
: Hepatectomy for HCC in cirrhosis is affected by the risk of PLF, which is not completely predictable with common biochemical tests. Transient elastography with FibroScan is used to calculate the degree of LS, and it may be applicable to patients scheduled for hepatectomy to estimate perioperative complications.
: Ninety-two patients undergoing hepatectomy for HCC were prospectively evaluated with preoperative FibroScan. Accuracy of LS measurement in predicting PLF, the presence of cirrhosis, and the presence of clinical signs of portal hypertension (PH) were assessed using receiver operating characteristic (ROC) analysis.
: In 2 patients, LS measurement could not be performed because of obesity; consequently, 90 patients were suitable for the study. Perioperative mortality was 2.2% (2 patients); PLF occurred in 28.9% of patients (26 patients). ROC analysis identified patients with LS value higher than or equal to 15.7 kPa as being at higher risk of PLF [area under the curve (AUC) = 0.865, 95% confidence interval: 0.776-0.928; sensitivity = 96.1%; specificity = 68.7%; positive predictive value = 55.6%; negative predictive value = 97.8%; positive likelihood ratio = 3.08; negative likelihood ratio = 0.056; P < 0.001]. Patients with LS value lower than 14.8 kPa had no PLF. LS value higher than 12.6 kPa and higher than 19.6 kPa was correlated with the presence of cirrhosis (AUC = 0.880; P < 0.001), and of PH (AUC = 0.786; P < 0.001), respectively. Multivariate analysis showed that low preoperative serum sodium levels (P = 0.012), histological cirrhosis (P = 0.024), and elevated LS (P = 0.005) were independent predictors of PLF.
: LS measured with FibroScan is a valid tool for prediction of PLF in patients undergoing hepatectomy for HCC.
评估术前肝脏硬度(LS)测量在预测肝细胞癌(HCC)肝切除术后肝功能衰竭(PLF)中的疗效。
肝硬化患者行 HCC 肝切除受 PLF 风险的影响,而普通生化检测并不能完全预测该风险。瞬时弹性成像技术(FibroScan)用于计算 LS 程度,可能适用于接受肝切除术的患者,以评估围手术期并发症。
前瞻性评估 92 例行 HCC 肝切除术的患者的术前 FibroScan。采用受试者工作特征(ROC)分析评估 LS 测量在预测 PLF、肝硬化和临床门静脉高压(PH)体征中的准确性。
2 例患者因肥胖无法进行 LS 测量;因此,90 例患者适合研究。2 例患者(2.2%)发生围手术期死亡;26 例患者(28.9%)发生 PLF。ROC 分析发现 LS 值大于或等于 15.7 kPa 的患者发生 PLF 的风险较高 [曲线下面积(AUC)= 0.865,95%置信区间:0.776-0.928;灵敏度=96.1%;特异性=68.7%;阳性预测值=55.6%;阴性预测值=97.8%;阳性似然比=3.08;阴性似然比=0.056;P<0.001]。LS 值小于 14.8 kPa 的患者无 PLF。LS 值大于 12.6 kPa 和大于 19.6 kPa 分别与肝硬化(AUC=0.880;P<0.001)和 PH(AUC=0.786;P<0.001)的存在相关。多变量分析显示,术前血清钠水平较低(P=0.012)、组织学肝硬化(P=0.024)和 LS 升高(P=0.005)是 PLF 的独立预测因素。
FibroScan 测量的 LS 是预测 HCC 肝切除术后 PLF 的有效工具。